Background The airways of patients with cystic fibrosis (CF) are highly complex, subject to
various environmental conditions as well as a distinct microbiota. Pseudomonas aeruginosa …

Staphylococcus aureus is an important cause of skin and soft-tissue infections (SSTIs),
endovascular infections, pneumonia, septic arthritis, endocarditis, osteomyelitis, foreign …

Small colony variants (SCVs) were first described more than 100 years ago for
Staphylococcus aureus and various coagulase-negative staphylococci. Two decades ago …

The 2013 Infection Prevention and Control (IP&C) Guideline for Cystic Fibrosis (CF) was
commissioned by the CF Foundation as an update of the 2003 Infection Control Guideline …

Meticillin-resistant Staphylococcus aureus (MRSA) is endemic in hospitals worldwide, and
causes substantial morbidity and mortality. Health-care-associated MRSA infections arise in …

In patients with cystic fibrosis (CF) lung damage secondary to chronic infection is the main
cause of death. Treatment of lung disease to reduce the impact of infection, inflammation …

Although survival of individuals with cystic fibrosis (CF) has been continuously improving for
the past 40 years, respiratory failure secondary to recurrent pulmonary infections remains …

Rationale: Patients with cystic fibrosis periodically experience pulmonary exacerbations.
Previous studies have noted that some patients' lung function (FEV1) does not improve with …

SUMMARY A select group of microorganisms inhabit the airways of individuals with cystic
fibrosis. Once established within the pulmonary environment in these patients, many of …

Background The relevance of Aspergillus fumigatus in patients with cystic fibrosis (CF) not
affected by allergic bronchopulmonary aspergillosis is unclear. Our aim was to determine …